Ardelyx
Focus: Ardelyx is a gastrointestinal-focused biotech company headquartered in Fremont, CA, with commercial operations centered on IBSRELA (tenapanor) for IBS-C in adults.
Profile data last refreshed 5m ago · AI intelligence enriched 3w ago
Open Jobs
5
Should You Work at Ardelyx?
AI assessmentStrong fit for commercial and product roles riding a validated peak-stage asset, but high risk for R&D and long-term career stability due to pipeline depth and single-product dependency.
Why Work Here
- Peak-stage product (IBSRELA) generating $34M in Part D spending with patent protection through 2042, providing revenue stability and commercial execution visibility.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$34M Part DStable
Peak
Help build intelligence for Ardelyx
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.